Moderna applies for US clearance of COVID shot for young kids
Moderna Inc. applied for emergency use authorization for its COVID-19 vaccine in children from six months to under 6 years old after a successful trial showed two doses generate high levels of antibodies to the virus.
Tribune News Service ·